Shares of Ophthalmic Goods company Bausch + Lomb climbed 5.7% this afternoon. Here are some quick facts to get you started if you are interested in the stock:
-
Bausch + Lomb has logged a -20.4% 52 week change, compared to 19.0% for the S&P 500
-
BLCO has an average analyst rating of buy and is -36.39% away from its mean target price of $26.27 per share
-
Its trailing earnings per share (EPS) is $-0.96, which brings its trailing Price to Earnings (P/E) ratio to -17.4. The Health Care sector's average P/E ratio is 27.61
-
The company's forward earnings per share (EPS) is $1.21 and its forward P/E ratio is 13.8
-
The company has a Price to Book (P/B) ratio of 0.88 in contrast to the Health Care sector's average P/B ratio is 3.69
-
The current ratio is currently 1.7, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $-198000000 and the average free cash flow growth rate is -39.0%
-
Bausch + Lomb's revenues have an average growth rate of 4.9% with operating expenses growing at 9.5%. The company's current operating margins stand at 3.1%